Association between molecular subtypes of colorectal cancer and patient survival - Wikidata - awgldk - TriplyDB

Association between molecular subtypes of colorectal cancer and patient survival

Association between molecular subtypes of colorectal cancer and patient survival

http://www.wikidata.org/entity/Q34759064

about

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy Tumour Cell Heterogeneity Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review Molecular phenotypes of colorectal cancer and potential clinical applications Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective Sessile serrated adenoma/polyps: Where are we at in 2016?Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer Gut microbiota and colorectal cancer.Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype.Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer.Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.Microsatellite instability testing and its role in the management of colorectal cancer.Molecular pathological epidemiology gives clues to paradoxical findings Colorectal Cancer: Personalized Therapy.Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer Mutational profiling of colorectal cancers with microsatellite instability.TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up.Advances in Fecal Tests for Colorectal Cancer Screening Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.Colorectal cancer carcinogenesis: a review of mechanisms

P2860

Q26747329-6921D2CC-3B08-45FF-803C-65CE27A48CEB Q26751035-B4C7CA0A-9D9F-44B8-9F26-AAEC69C11ADC Q26765895-AD172A90-58E6-494B-948F-8E8428C487E3 Q26768471-D3BE2791-CC8D-4D58-AB97-A49DF3BB16F0 Q26785725-D45E6D81-65CA-42DC-B47C-3E5BB4E2AD40 Q26795609-6566B2B1-83C7-4B91-9794-DF02E8767843 Q27005952-D92DAA68-A0E7-4978-AD6A-EA9304068F28 Q28066004-126CF157-5589-4EF1-BD2F-3038523633AE Q28070038-9343E6CC-94E1-4277-B6EF-D6E9C85B75A7 Q28076845-7A49ED92-D075-43F7-8534-DE1CBA0E010F Q28084216-BA584FA2-FFB9-4026-A86F-4997B0132866 Q28084346-7F9BDEF8-561D-4BEB-93CA-7D313CCC6F58 Q30239806-EC874E66-5CF2-46D2-9173-6C549B3C34AE Q30244608-FEA2CA97-33F0-41D0-A2E3-5408757E3EA1 Q30353497-FBFA690D-E21A-4113-B8A1-EDF623F2A0A4 Q30975797-711C2CDD-7481-45C9-8542-5E810A18DBEE Q33577619-2912D033-703B-4306-809F-4E18B8BFA88C Q33608167-78653785-D5AC-4CC3-8A8E-572EA93BF081 Q33630343-DA03E1A4-D508-4A75-9114-8D83803A0CC9 Q33696207-ADF70915-FD42-4685-B789-EC203B24141D Q34502713-B65296A8-39A4-4FD2-B2B2-DCAA47C6FF50 Q35229101-CCBFAF39-D511-4AD1-A81D-35B674425395 Q35722688-0DEBD172-E293-4F3D-97C5-2A53CFD55F41 Q35896952-5454A15B-8F0F-4F38-BE01-2B08BCE45058 Q35925613-D27C48AF-FEC8-4B56-9972-DF8434476E83 Q35956384-90A10ADE-7A8C-4CA8-BF4F-3455F90796AC Q36081402-CD7C0BF1-D254-4276-A092-DCE39FACB37C Q36086848-3F39B905-13D4-4F17-ACFC-35226BB7EFD4 Q36124008-0215E6FA-0405-43CB-898C-5AFC950C0F35 Q36264731-2020989B-DCA5-49AD-A944-6ED43C125148 Q36344547-99083C26-F055-4C6C-844D-2155D7D2B56C Q36345775-BFE2FBD6-A9F0-43E3-AF56-8242A13867AC Q36463826-E6549EEA-C994-4B19-97DE-7317EBA69963 Q36515055-CEF4B892-CB3F-4B51-9B86-77821671440E Q36561768-6C0E5739-9F4E-4C50-8BE6-DDF228ED17CA Q36580973-6E6BA60D-F052-4400-B598-D74ED01965A6 Q36665695-08AF7658-DC5B-42E3-B349-0DA07C3E05E3 Q36730670-6A4763A1-3C8A-4E09-B227-6993D32B7B85 Q36813582-EDCB85DB-EA90-442F-BC19-00444F4B8E3B Q36849645-7EE37670-0180-46A3-ACA0-292243923971

P2860

Association between molecular subtypes of colorectal cancer and patient survival

http://www.wikidata.org/entity/Q34759064

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Association between molecular subtypes of colorectal cancer and patient survival

@ast

Association between molecular subtypes of colorectal cancer and patient survival

@en

Association between molecular subtypes of colorectal cancer and patient survival

@nl

type

label

Association between molecular subtypes of colorectal cancer and patient survival

@ast

Association between molecular subtypes of colorectal cancer and patient survival

@en

Association between molecular subtypes of colorectal cancer and patient survival

@nl

prefLabel

Association between molecular subtypes of colorectal cancer and patient survival

@ast

Association between molecular subtypes of colorectal cancer and patient survival

@en

Association between molecular subtypes of colorectal cancer and patient survival

@nl

P1433

Q34759064-DD6C5D56-F980-4CB6-AF81-3887C4C0CB89

P1476

Q34759064-B49C6EB7-8478-4D61-B630-A63F12BFD1CF

P2093

Q34759064-1951706B-17B3-4B90-AE7C-B9C1B717291C

Q34759064-4AFF0C8B-0D4E-4DAC-865F-F34485FED205

Q34759064-66B2132D-7D0D-4AB6-A03C-503B214975B7

Q34759064-6DFDE7FB-057F-4237-9E63-F4054C1BB83F

Q34759064-8DE637BA-72F1-4E2D-B594-476A8F892BBF

Q34759064-9F775A82-94DE-4749-9576-F9897A074690

Q34759064-C4AFF456-9EEA-4177-9A44-F50C148DFFFF

P2860

Q34759064-005B1DE2-141F-464C-9EE4-0CD50778220F

Q34759064-0DA6B20D-49A1-4EEB-8E13-47F0570145D3

Q34759064-0DD0571C-9AD9-4B06-89CB-999C9DEDCAAE

Q34759064-1840CF2D-A899-4E0B-9B0C-5F52E6AC026F

Q34759064-1B29B348-61DA-495E-82A4-514EE2BC2BBA

Q34759064-2DAEFC3E-7DC6-4023-A7BD-AB433EEF5F64

Q34759064-2FF4F8E2-4E04-4E34-A985-D482911F6F2D

Q34759064-3301A049-8B51-4038-97B6-5E3F4478579F

Q34759064-4A5720AD-9BFF-4A0A-A1E4-E6FA9112836A

Q34759064-4B82C1C6-C320-4F75-A969-55635288214B

P304

Q34759064-AD00A4E4-6E16-4AD1-9802-8EDEA2DE8E35

P31

Q34759064-8F3499FF-B159-4A9E-A988-4FB33EDB7BF8

P356

Q34759064-194FEAB6-4F42-42CF-A01A-7656986C980B

P407

Q34759064-BDE7694A-AAC1-42DA-9B54-87DDFC1079CE

P433

Q34759064-1632DB8E-BCB3-4418-8FC2-8661A245577A

P478

Q34759064-51F5A6FF-B1DA-4451-A67D-613A207A15D6

P50

Q34759064-78B7B14E-1328-411E-8CD5-EDBDD63C2B97

Q34759064-7BAFC043-E5E5-4592-982B-8920C4FBFFFE

Q34759064-E2B92503-BADE-4B4A-9AB5-2772DE020810

Q34759064-E9E0406B-3352-460F-86BE-7C1ADBB256ED

P577

Q34759064-22C00C6B-295D-4519-ACC3-BBEDA5255B59

P698

Q34759064-0BDF05A5-24FC-47B2-81B1-826932EE0368

P921

Q34759064-D16DB080-B5B6-4370-82FC-A3736D5E38CC

Q34759064-F87BD913-7CE5-442C-9B76-C8A110D226E5

P932

Q34759064-5738004A-63D7-4CA8-B248-64E553B15F23

P356

J.GASTRO.2014.09.038

P1433

Gastroenterology

P1476

Association between molecular subtypes of colorectal cancer and patient survival

@en

P2093

Amanda I Phipps

http://www.w3.org/2001/XMLSchema#string

Andrea N Burnett-Hartman

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisenberger

http://www.w3.org/2001/XMLSchema#string

Frank A Sinicrope

http://www.w3.org/2001/XMLSchema#string

John A Baron

http://www.w3.org/2001/XMLSchema#string

Paul J Limburg

http://www.w3.org/2001/XMLSchema#string

Peter W Laird

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Mutations of the BRAF gene in human cancer

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Systematic review of microsatellite instability and colorectal cancer prognosis

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.

Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics

P304

77-87.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2014.09.038

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Daniel D Buchanan

Christophe Rosty

Polly A Newcomb

P577

2014-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25280443

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4274235

http://www.w3.org/2001/XMLSchema#string